Global Clinical Treatment for Covid-19 Market Growth (Status and Outlook) 2023-2029

March 2023 | 100 pages | ID: G99700581203EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, the global Clinical Treatment for Covid-19 market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Treatment for Covid-19 market by product type, application, key players and key regions and countries.

Segmentation by product type:

• Antimicrobial Therapy
• Renal Failure and Renal Replacement Therapy
• Lung Replacement Therapy
• Immunotherapy
• Others

Segmentation by Application:

• Children
• Adult
• Special Groups

This report also splits the market by region:

• United States
• China
• Europe
• Other regions:
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Applied DNA Sciences, Inc
• Codagenix
• GeoVax Labs, Inc.
• Takis Biotech
• Evvivax
• Zydus Cadila
• MIGAL Galilee Research Institute
• Generex Biotechnology Corporation
• Moderna Therapeutics
• Novavax
• Bravovax
• Ascletis Pharma
• Janssen Pharmaceuticals
• Altimmune
• Greffex Inc.
• CanSino Biologics, Inc.
• ExpreS2ion Biotechnologies ApS
• Clover Biopharmaceuticals
• Vaxil Bio Ltd.
• iBio Pharma Inc
• Tonix Pharmaceuticals
• Curevac
• ImmunoPrecise

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Clinical Treatment for Covid-19 Market Size 2024-2029
  2.1.2 Clinical Treatment for Covid-19 Market Size CAGR by Region
2.2 Clinical Treatment for Covid-19 Segment by Type
  2.2.1 Antimicrobial Therapy
  2.2.2 Renal Failure and Renal Replacement Therapy
  2.2.3 Lung Replacement Therapy
  2.2.4 Immunotherapy
  2.2.5 Others
2.3 Clinical Treatment for Covid-19 Market Size by Type
  2.3.1 Global Clinical Treatment for Covid-19 Market Size Market Share by Type (2024-2029)
  2.3.2 Global Clinical Treatment for Covid-19 Market Size Growth Rate by Type (2024-2029)
2.4 Clinical Treatment for Covid-19 Segment by Application
  2.4.1 Children
  2.4.2 Adult
  2.4.3 Special Groups
2.5 Clinical Treatment for Covid-19 Market Size by Application
  2.5.1 Global Clinical Treatment for Covid-19 Market Size Market Share by Application (2024-2029)
  2.5.2 Global Clinical Treatment for Covid-19 Market Size Growth Rate by Application (2024-2029)

3 CLINICAL TREATMENT FOR COVID-19 KEY PLAYERS

3.1 Date of Key Players Enter into Clinical Treatment for Covid-19
3.2 Key Players Clinical Treatment for Covid-19 Product Offered
3.3 Key Players Clinical Treatment for Covid-19 Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players Clinical Treatment for Covid-19 Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 CLINICAL TREATMENT FOR COVID-19 BY REGIONS

4.1 Clinical Treatment for Covid-19 Market Size by Regions (2024-2029)
4.2 United States Clinical Treatment for Covid-19 Market Size Growth (2024-2029)
4.3 China Clinical Treatment for Covid-19 Market Size Growth (2024-2029)
4.4 Europe Clinical Treatment for Covid-19 Market Size Growth (2024-2029)
4.5 Rest of World Clinical Treatment for Covid-19 Market Size Growth (2024-2029)

5 UNITED STATES

5.1 United States Clinical Treatment for Covid-19 Market Size by Type (2024-2029)
5.2 United States Clinical Treatment for Covid-19 Market Size by Application (2024-2029)

6 EUROPE

6.1 Europe Clinical Treatment for Covid-19 Market Size by Type (2024-2029)
6.2 Europe Clinical Treatment for Covid-19 Market Size by Application (2024-2029)

7 CHINA

7.1 China Clinical Treatment for Covid-19 Market Size by Type (2024-2029)
7.2 China Clinical Treatment for Covid-19 Market Size by Application (2024-2029)

8 REST OF WORLD

8.1 Rest of World Clinical Treatment for Covid-19 Market Size by Type (2024-2029)
8.2 Rest of World Clinical Treatment for Covid-19 Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN CLINICAL TREATMENT FOR COVID-19

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 Applied DNA Sciences, Inc
  11.1.1 Applied DNA Sciences, Inc Company Details
  11.1.2 Applied DNA Sciences, Inc Clinical Treatment for Covid-19 Product Offered
  11.1.3 Applied DNA Sciences, Inc Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
  11.1.4 Applied DNA Sciences, Inc Main Business Overview
  11.1.5 Applied DNA Sciences, Inc News
11.2 Codagenix
  11.2.1 Codagenix Company Details
  11.2.2 Codagenix Clinical Treatment for Covid-19 Product Offered
  11.2.3 Codagenix Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
  11.2.4 Codagenix Main Business Overview
  11.2.5 Codagenix News
11.3 GeoVax Labs, Inc.
  11.3.1 GeoVax Labs, Inc. Company Details
  11.3.2 GeoVax Labs, Inc. Clinical Treatment for Covid-19 Product Offered
  11.3.3 GeoVax Labs, Inc. Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
  11.3.4 GeoVax Labs, Inc. Main Business Overview
  11.3.5 GeoVax Labs, Inc. News
11.4 Takis Biotech
  11.4.1 Takis Biotech Company Details
  11.4.2 Takis Biotech Clinical Treatment for Covid-19 Product Offered
  11.4.3 Takis Biotech Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
  11.4.4 Takis Biotech Main Business Overview
  11.4.5 Takis Biotech News
11.5 Evvivax
  11.5.1 Evvivax Company Details
  11.5.2 Evvivax Clinical Treatment for Covid-19 Product Offered
  11.5.3 Evvivax Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
  11.5.4 Evvivax Main Business Overview
  11.5.5 Evvivax News
11.6 Zydus Cadila
  11.6.1 Zydus Cadila Company Details
  11.6.2 Zydus Cadila Clinical Treatment for Covid-19 Product Offered
  11.6.3 Zydus Cadila Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
  11.6.4 Zydus Cadila Main Business Overview
  11.6.5 Zydus Cadila News
11.7 MIGAL Galilee Research Institute
  11.7.1 MIGAL Galilee Research Institute Company Details
  11.7.2 MIGAL Galilee Research Institute Clinical Treatment for Covid-19 Product Offered
  11.7.3 MIGAL Galilee Research Institute Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
  11.7.4 MIGAL Galilee Research Institute Main Business Overview
  11.7.5 MIGAL Galilee Research Institute News
11.8 Generex Biotechnology Corporation
  11.8.1 Generex Biotechnology Corporation Company Details
  11.8.2 Generex Biotechnology Corporation Clinical Treatment for Covid-19 Product Offered
  11.8.3 Generex Biotechnology Corporation Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
  11.8.4 Generex Biotechnology Corporation Main Business Overview
  11.8.5 Generex Biotechnology Corporation News
11.9 Moderna Therapeutics
  11.9.1 Moderna Therapeutics Company Details
  11.9.2 Moderna Therapeutics Clinical Treatment for Covid-19 Product Offered
  11.9.3 Moderna Therapeutics Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
  11.9.4 Moderna Therapeutics Main Business Overview
  11.9.5 Moderna Therapeutics News
11.10 Novavax
  11.10.1 Novavax Company Details
  11.10.2 Novavax Clinical Treatment for Covid-19 Product Offered
  11.10.3 Novavax Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
  11.10.4 Novavax Main Business Overview
  11.10.5 Novavax News
11.11 Bravovax
11.12 Ascletis Pharma
11.13 Janssen Pharmaceuticals
11.14 Altimmune
11.15 Greffex Inc.
11.16 CanSino Biologics, Inc.
11.17 ExpreS2ion Biotechnologies ApS
11.18 Clover Biopharmaceuticals
11.19 Vaxil Bio Ltd.
11.20 iBio Pharma Inc
11.21 Tonix Pharmaceuticals
11.22 Curevac
11.23 ImmunoPrecise

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Clinical Treatment for Covid-19 Market Size CAGR by Region (2024-2029) ($ Millions)
Table 2. Major Players of Antimicrobial Therapy
Table 3. Major Players of Renal Failure and Renal Replacement Therapy
Table 4. Major Players of Lung Replacement Therapy
Table 5. Major Players of Immunotherapy
Table 6. Major Players of Others
Table 7. Global Clinical Treatment for Covid-19 Market Size by Type (2024-2029) ($ Millions)
Table 8. Global Clinical Treatment for Covid-19 Market Size Market Share by Type (2024-2029)
Table 9. Global Clinical Treatment for Covid-19 Market Size by Application (2024-2029) ($ Millions)
Table 10. Global Clinical Treatment for Covid-19 Market Size Market Share by Application (2024-2029)
Table 11. Date of Global Key Players Enter into Clinical Treatment for Covid-19 Market
Table 12. Global Key Players Clinical Treatment for Covid-19 Product Offered
Table 13. Key Players Clinical Treatment for Covid-19 Funding/Investment ($ Millions)
Table 14. Funding/Investment by Regions
Table 15. Funding/Investment by End Industry
Table 16. Key Players Clinical Treatment for Covid-19 Valuation & Market Capitalization ($ Millions)
Table 17. Key Players Mergers & Acquisitions, Expansion Plans
Table 18. Clinical Treatment for Covid-19 New Product/Technology Launches
Table 19. Clinical Treatment for Covid-19 Industry Partnerships, Agreements, and Collaborations
Table 20. Clinical Treatment for Covid-19 Industry Mergers and Acquisitions
Table 21. Global Clinical Treatment for Covid-19 Market Size by Regions 2024-2029 ($ Millions)
Table 22. Global Clinical Treatment for Covid-19 Market Size Market Share by Regions 2024-2029
Table 23. United States Clinical Treatment for Covid-19 Market Size by Type (2024-2029) ($ Millions)
Table 24. United States Clinical Treatment for Covid-19 Market Size Market Share by Type (2024-2029)
Table 25. United States Clinical Treatment for Covid-19 Market Size by Application (2024-2029) ($ Millions)
Table 26. United States Clinical Treatment for Covid-19 Market Size Market Share by Application (2024-2029)
Table 27. Europe Clinical Treatment for Covid-19 Market Size by Type (2024-2029) ($ Millions)
Table 28. Europe Clinical Treatment for Covid-19 Market Size Market Share by Type (2024-2029)
Table 29. Europe Clinical Treatment for Covid-19 Market Size by Application (2024-2029) ($ Millions)
Table 30. Europe Clinical Treatment for Covid-19 Market Size Market Share by Application (2024-2029)
Table 31. China Clinical Treatment for Covid-19 Market Size by Type (2024-2029) ($ Millions)
Table 32. China Clinical Treatment for Covid-19 Market Size Market Share by Type (2024-2029)
Table 33. China Clinical Treatment for Covid-19 Market Size by Application (2024-2029) ($ Millions)
Table 34. China Clinical Treatment for Covid-19 Market Size Market Share by Application (2024-2029)
Table 35. Rest of World Clinical Treatment for Covid-19 Market Size by Type (2024-2029) ($ Millions)
Table 36. Rest of World Clinical Treatment for Covid-19 Market Size Market Share by Type (2024-2029)
Table 37. Rest of World Clinical Treatment for Covid-19 Market Size by Application (2024-2029) ($ Millions)
Table 38. Rest of World Clinical Treatment for Covid-19 Market Size Market Share by Application (2024-2029)
Table 39. Key Market Drivers & Growth Opportunities of Clinical Treatment for Covid-19
Table 40. Key Market Challenges & Risks of Clinical Treatment for Covid-19
Table 41. Key Industry Trends of Clinical Treatment for Covid-19
Table 42. Company A Company Details
Table 43. Companies Invested by Company A
Table 44. Company A Key Development and Market Layout
Table 45. Company B Company Details
Table 46. Companies Invested by Company B
Table 47. Company B Key Development and Market Layout
Table 48. Company C Company Details
Table 49. Companies Invested by Company C
Table 50. Company C Key Development and Market Layout
Table 51. Company C Company Details
Table 52. Companies Invested by Company C
Table 53. Company C Key Development and Market Layout
Table 54. Applied DNA Sciences, Inc Basic Information, Head Office, Major Market Areas and Its Competitors
Table 55. Applied DNA Sciences, Inc Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 56. Codagenix Basic Information, Head Office, Major Market Areas and Its Competitors
Table 57. Codagenix Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 58. GeoVax Labs, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. GeoVax Labs, Inc. Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 60. Takis Biotech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. Takis Biotech Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 62. Evvivax Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Evvivax Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 64. Zydus Cadila Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Zydus Cadila Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 66. MIGAL Galilee Research Institute Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. MIGAL Galilee Research Institute Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 68. Generex Biotechnology Corporation Basic Information, Head Office, Major Market Areas and Its Competitors
Table 69. Generex Biotechnology Corporation Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 70. Moderna Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 71. Moderna Therapeutics Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 72. Novavax Basic Information, Head Office, Major Market Areas and Its Competitors
Table 73. Novavax Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 74. Bravovax Basic Information, Head Office, Major Market Areas and Its Competitors
Table 75. Bravovax Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 76. Ascletis Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 77. Ascletis Pharma Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 78. Janssen Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 79. Janssen Pharmaceuticals Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 80. Altimmune Basic Information, Head Office, Major Market Areas and Its Competitors
Table 81. Altimmune Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 82. Greffex Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 83. Greffex Inc. Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 84. CanSino Biologics, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 85. CanSino Biologics, Inc. Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 86. ExpreS2ion Biotechnologies ApS Basic Information, Head Office, Major Market Areas and Its Competitors
Table 87. ExpreS2ion Biotechnologies ApS Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 88. Clover Biopharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 89. Clover Biopharmaceuticals Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 90. Vaxil Bio Ltd. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 91. Vaxil Bio Ltd. Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 92. iBio Pharma Inc Basic Information, Head Office, Major Market Areas and Its Competitors
Table 93. iBio Pharma Inc Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 94. Tonix Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 95. Tonix Pharmaceuticals Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 96. Curevac Basic Information, Head Office, Major Market Areas and Its Competitors
Table 97. Curevac Clinical Treatment for Covid-19 Market Size (2023 VS 2029)
Table 98. ImmunoPrecise Basic Information, Head Office, Major Market Areas and Its Competitors
Table 99. ImmunoPrecise Clinical Treatment for Covid-19 Market Size (2023 VS 2029)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Clinical Treatment for Covid-19
Figure 2. Clinical Treatment for Covid-19 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Clinical Treatment for Covid-19 Market Size Growth Rate 2024-2029 ($ Millions)
Figure 7. Clinical Treatment for Covid-19 Market Size by Region (2023 & 2029) ($ millions)
Figure 8. Global Clinical Treatment for Covid-19 Market Size Market Share by Type (2024-2029)
Figure 9. Global Antimicrobial Therapy Market Size Growth Rate
Figure 10. Global Renal Failure and Renal Replacement Therapy Market Size Growth Rate
Figure 11. Global Lung Replacement Therapy Market Size Growth Rate
Figure 12. Global Immunotherapy Market Size Growth Rate
Figure 13. Global Others Market Size Growth Rate
Figure 14. Clinical Treatment for Covid-19 in Children
Figure 15. Global Clinical Treatment for Covid-19 Market: Children (2024-2029) ($ Millions)
Figure 16. Clinical Treatment for Covid-19 in Adult
Figure 17. Global Clinical Treatment for Covid-19 Market: Adult (2024-2029) ($ Millions)
Figure 18. Clinical Treatment for Covid-19 in Special Groups
Figure 19. Global Clinical Treatment for Covid-19 Market: Special Groups (2024-2029) ($ Millions)
Figure 20. Global Clinical Treatment for Covid-19 Market Size Market Share by Application (2024-2029)
Figure 21. Global Clinical Treatment for Covid-19 Market Size in Children Growth Rate
Figure 22. Global Clinical Treatment for Covid-19 Market Size in Adult Growth Rate
Figure 23. Global Clinical Treatment for Covid-19 Market Size in Special Groups Growth Rate
Figure 24. Funding/Investment
Figure 25. Global Clinical Treatment for Covid-19 Market Size Market Share by Regions 2024-2029
Figure 26. United States Clinical Treatment for Covid-19 Market Size 2024-2029 ($ Millions)
Figure 27. China Clinical Treatment for Covid-19 Market Size 2024-2029 ($ Millions)
Figure 28. Europe Clinical Treatment for Covid-19 Market Size 2024-2029 ($ Millions)
Figure 29. Rest of World Clinical Treatment for Covid-19 Market Size 2024-2029 ($ Millions)
Figure 30. United States Clinical Treatment for Covid-19 Consumption Market Share by Type in 2029
Figure 31. United States Clinical Treatment for Covid-19 Market Size Market Share by Application in 2029
Figure 32. China Clinical Treatment for Covid-19 Consumption Market Share by Type in 2029
Figure 33. China Clinical Treatment for Covid-19 Market Size Market Share by Application in 2029
Figure 34. Europe Clinical Treatment for Covid-19 Consumption Market Share by Type in 2029
Figure 35. Europe Clinical Treatment for Covid-19 Market Size Market Share by Application in 2029
Figure 36. Rest of World Clinical Treatment for Covid-19 Consumption Market Share by Type in 2029
Figure 37. Rest of World Clinical Treatment for Covid-19 Market Size Market Share by Application in 2029